Benlysta ratings & reviews

Belimumab
Company: GSK
Brand: Benlysta
Drug class: Antineoplastic and Immunomodulating Agents
+6 more
Antineoplastic and Immunomodulating Agents, Musculo-Skeletal System, Agents that Suppress the Immune System, Antiinflammatory Agents and Antirheumatic Agents, B Lymphocyte Stimulator (BLyS) Inhibitors, Specific Anti-Rheumatic Agents, Anti-Rheumatic Monoclonal Antibodies

Sermo AI Overview

  • In systemic lupus erythematosus (SLE), Benlysta is considered a positive treatment, especially for those with mild symptoms relying on steroids, but it may be seen more as an adjunct treatment rather than first-line therapy for severe cases.
  • Physicians have noted that individual considerations are crucial when prescribing Benlysta, as some patients experience only moderate efficacy for severe forms of SLE. Access issues and varying adherence rates are important factors to manage.
  • Benlysta is recognized for its effectiveness in treating lupus nephritis, particularly in autoantibody-positive patients, and is seen as a valuable option in rheumatology and nephrology. However, accessibility can vary, impacting adherence for some individuals.
  • While Benlysta is generally well-tolerated with a favorable safety profile, careful monitoring is recommended due to potential side effects like infections. Patients often face challenges with insurance coverage and treatment continuity, complicating its usage.
Based on insights from Sermo’s triple verified physicians

Description

Benlysta's active ingredient is belimumab, a human IgG1λ monoclonal antibody used as a specific inhibitor of the B lymphocyte stimulator protein (BLyS). It is available as a clear to pale yellow injection for subcutaneous use, in 1-mL single-dose autoinjectors or prefilled syringes, each containing 200 mg of belimumab. Key inactive ingredients include L-arginine hydrochloride, L-histidine, L-histidine monohydrochloride, polysorbate 80, and sodium chloride. The solution is designed for administration via a fixed 27-gauge, half-inch needle.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is injected into a vein or under the skin. Injections into a vein are given by your care team in a hospital or clinic setting. Injections under the skin may be given at home. If you get this medication at home, you will be taught how to prepare and give it. Use exactly as directed. Take it as directed on the prescription label. Keep taking it unless your care team tells you to stop. This medication comes with INSTRUCTIONS FOR USE. Ask your pharmacist for directions on how to use this medication. Read the information carefully. Talk to your pharmacist or care team if you have questions. It is important that you put your used needles and syringes in a special sharps container. Do not put them in a trash can. If you do not have a sharps container, call your pharmacist or care team to get one. A special MedGuide will be given to you by the pharmacist with each prescription and refill. If you are getting this medication in a hospital or clinic, a special MedGuide will be given to you before each treatment. Be sure to read this information carefully each time. Talk to your care team about the use of this medication in children. While it be prescribed for children as young as 5 years for selected conditions, precautions do apply.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

If you get this medication at the hospital or clinic: It is important not to miss your dose. Call your care team if you are unable to keep an appointment. If you give yourself this medication at home: If you miss a dose, take it as soon as you can. Then, resume dosing on the usual day you get your medication or start a new weekly dosing schedule from the day that the missed dose was given. If it is almost time for your next dose, take only that dose. Do not take double or extra doses. Call your care team with questions.

Where should I keep my medication?

Keep out of the reach of children and pets. Store in the refrigerator. Do not freeze. Keep this medication in the original container until you are ready to take it. Protect from light. Avoid exposure to extreme heat. Get rid of any unused medication after the expiration date. Do not use this medication or put it back in the refrigerator if it is left out at room temperature for more than 12 hours. If it is stored at room temperature, throw away any unused medication after 12 hours or after it expires, whichever is first. To get rid of medications that are no longer needed or have expired: -Take the medication to a medication take-back program. Check with your pharmacy or law enforcement to find a location. -If you cannot return the medication, ask your pharmacist or care team how to get rid of this medication safely.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible: -Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat -Dizziness, loss of balance or coordination, confusion or trouble speaking -Infection—fever, chills, cough, sore throat, wounds that don't heal, pain or trouble when passing urine, general feeling of discomfort or being unwell -Thoughts of suicide or self-harm, worsening mood, or feelings of depression Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome): -Diarrhea -Headache -Nausea -Pain, redness, or irritation at injection site -Runny or stuffy nose -Trouble sleeping

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions: -Cancer -Depression -Immune system problems -Infection -Recent or upcoming vaccine -Suicidal thoughts, plans, or attempt -An unusual or allergic reaction to belimumab, other medications, foods, dyes, or preservatives -Pregnant or trying to get pregnant -Breastfeeding

What may interact with this medication?

Do not take this medication with any of the following: -Live virus vaccines This medication may also interact with the following: -Biologic medications, such as adalimumab, certolizumab, etanercept, golimumab, infliximab -Cyclophosphamide -Monoclonal antibodies, such as ocrelizumab, ofatumumab, rituximab

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse. This medication may increase your risk of getting an infection. Call your care team for advice if you get a fever, chills, sore throat, or other symptoms of a cold or flu. Do not treat yourself. Try to avoid being around people who are sick. In some patients, this medication may cause a serious brain infection that may cause death. If you have any problems seeing, thinking, speaking, walking, or standing, tell your care team right away. If you cannot reach your care team, urgently seek another source of medical care. Talk to your care team about your risk of cancer. You may be more at risk for certain types of cancer if you take this medication.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence